William Stanton

William Stanton is an associate in the firm’s Business Law department and a member of its Technology and Life Sciences groups, and Public M&A/Corporate governance practice.

His recent Public M&A experience includes representing:

• AlloVir in its proposed “reverse” merger with Kalaris Therapeutics
• Societal CDMO in its $130 million sale to CoreRx
• Renesas Electronics Corporation in various acquisitions, including its proposed $339 million acquisition of Transphorm
• PathosAI in its acquisition of Rain Oncology
• Surface Oncology in its sale to Coherus Biosciences for stock and contingent value rights (CVRs) valued at $66.9 million
• eMagin in its $218 million sale to Samsung Display
• Ritchie Bros. in its $7.3 billion acquisition of IAA, Inc.
• Rocket Pharmaceuticals in its acquisition of Renovacor 
• Edgio in its $300 million acquisition of Yahoo’s Edgecast business
• BioDelivery Sciences International in its $605 million sale to Collegium Pharmaceutical
• Roman DBDR Tech Acquisition Corp. (a SPAC) in its business combination with Composecure
• Retail Properties of America in its $7.5 billion sale to Kite Realty Group Trust
• Chiasma in its sale to Amryt Pharma
• Leaf Group in its $323 million sale to Graham Holdings Company
• Special Committee of NantKwest in NantKwest’s merger with ImmunityBio
• MyoKardia in connection with its $13.1 billion sale to Bristol-Myers Squibb Company
• Carbon Black in its $2.1 billion sale to VMware
• AMAG Pharmaceuticals in its $500 million sale to Covis Group, an Apollo Global Management company
• HelpSystems in its $217 million take-private of GlobalSCAPE
• Neon Therapeutics in its $97 million sale to BioNTech

His recent Private M&A experience includes representing:

• iCapital in its acquisition of AltExchange
• Deliver in its $2.1 billion sale to Shopify
• Axon Communications in its sale to Relevate Health
• TA Associates in numerous acquisitions and dispositions, including with respect to Wealth Enhancement Group, HelpSystems, Thermacell and Accion Labs
• Kingswood Capital Management in its acquisition and disposition of Senture
• Webster Equity Partners in its acquisition of Long Island Vitreoretinal Consultants

While attending law school, William served as Articles Editor on the Brooklyn Law Review.